FDA clears updated COVID-19 vaccines for kids under age 5

日本 ニュース ニュース

FDA clears updated COVID-19 vaccines for kids under age 5
日本 最新ニュース,日本 見出し
  • 📰 WOKVNews
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 63%

U.S. regulators have cleared doses of the updated COVID-19 vaccines to children younger than 5

Deborah Sampson, left, a nurse at a University of Washington Medical Center clinic in Seattle, gives a Pfizer COVID-19 vaccine shot to a 20-month-old child, June 21, 2022, in Seattle. The U.S. on Thursday, Dec. 8, 2022 open doses of the updated COVID-19 vaccines for most children younger than age 5.

The FDA now has cleared their use in tots starting at age 6 months -- but just who is eligible depends on what vaccinations they've already had, and which kind. Few youngsters have gotten the full primary series since shots for the littlest kids--Children under age 6 who’ve already gotten two original doses of Moderna’s COVID-19 vaccine can get a single booster of Moderna’s updated formula if it's been at least two months since their last shot.

--Children under 5 who already got all three Pfizer doses aren’t yet eligible for an updated booster. Data expected next month should help the FDA determine if and when those tots need the omicron-targeted booster. Just 3% of tots under 2 and nearly 5% of those 2 to 4 have gotten their primary doses so far, according to the CDC.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

WOKVNews /  🏆 247. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

FDA authorizes Covid omicron vaccines for children as young as 6 months oldFDA authorizes Covid omicron vaccines for children as young as 6 months old
続きを読む »

FDA authorizes updated COVID-19 boosters for kids under 5FDA authorizes updated COVID-19 boosters for kids under 5The U.S. Food and Drug Administration authorized bivalent COVID-19 boosters for children between ages 6 months and 4 years Thursday.
続きを読む »

Pfizer partners with Clear Creek Bio to develop oral COVID-19 drugPfizer partners with Clear Creek Bio to develop oral COVID-19 drugPfizer Inc and Clear Creek Bio Inc on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline.
続きを読む »

The flu, COVID-19 and RSV: Why health experts are concerned about this ‘tripledemic’The flu, COVID-19 and RSV: Why health experts are concerned about this ‘tripledemic’Hospitals are filling up with people battling both flu and COVID as well as with pediatric patients suffering from RSV. This is what health experts have deemed as the ‘tripledemic’ and there’s concern that these infections will continue to spread.
続きを読む »

COVID-19 surge continues building in LA County, with 3,100 new casesCOVID-19 surge continues building in LA County, with 3,100 new casesAccording to state figures, there were 1,270 COVID-positive patients in county hospitals as of Tuesday, up from 1,205 reported on Saturday.
続きを読む »



Render Time: 2025-03-13 01:52:42